InnoCan Pharma: Funding, Investors & Team (Sep 2026)
Cannabinoids interact with the endocannabinoid receptor system, which is located throughout the body and plays an important role in many processes. InnoCan aims to harness the power of cannabinoids to target a wide variety of health problems. InnoCan plans to initially innovate new dermatology treatments, where research shows topical cannabinoid-combined treatments are highly effective.
InnoCan Pharma has raised $5.0M across 3 funding rounds on record, the most recent an undisclosed round of $450k announced in Mar 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
InnoCan Pharma Company Profile and Key Stats
Latest funding round on record: Mar 2026.
InnoCan Pharma Funding Rounds
InnoCan Pharma raised $3.0M in an undisclosed round announced in Sep 2023.
6 months later, an undisclosed round of $1.5M was announced in Mar 2024.
2 years later, an undisclosed round of $450k was announced in Mar 2026.
InnoCan Pharma Founders and Leadership Team
Contact details for the InnoCan Pharma team: 1 of 1 has an email address on file.
Start 14-day free trial →InnoCan Pharma Funding Compared to Other Biotechnology Startups
InnoCan Pharma's latest round of $450k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like InnoCan Pharma in Biotechnology and Herzliya
Companies Similar to InnoCan Pharma
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
InnoCan Pharma Funding FAQs
What does InnoCan Pharma do?
Cannabinoids interact with the endocannabinoid receptor system, which is located throughout the body and plays an important role in many processes. InnoCan aims to harness the power of cannabinoids to target a wide variety of health problems. InnoCan plans to initially innovate new dermatology treatments, where research shows topical cannabinoid-combined treatments are highly effective.
How much funding has InnoCan Pharma raised?
InnoCan Pharma has raised $5.0M across 3 rounds on record. The most recent is an undisclosed round of $450k announced in Mar 2026.
When did InnoCan Pharma last raise funding?
InnoCan Pharma's most recent funding round on record is an undisclosed round of $450k, announced in Mar 2026.
Who founded InnoCan Pharma?
FundedIQ lists Iris Bincovich (Founder) at InnoCan Pharma.
Where is InnoCan Pharma headquartered?
InnoCan Pharma is based in Herzliya, Tel Aviv, Israel.
How many employees does InnoCan Pharma have?
InnoCan Pharma is in the 11-50 employee band.
How does InnoCan Pharma's funding compare to other Biotechnology startups?
InnoCan Pharma's latest round of $450k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's InnoCan Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for InnoCan Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.